GPD1 and urinary bladder carcinoma: Many differentially expressed proteins were identified, among which GPD1 expression was significantly decreased in bladder cancer and further validated that GPD1 overexpression showed a suppressive effect on tumor growth in vivo and in vitro, which suggests that GPD1 may be a novel therapeutic target for bladder cancer.